Dexmedetomidine and Blood Coagulation

CompletedOBSERVATIONAL
Enrollment

11

Participants

Timeline

Start Date

February 12, 2020

Primary Completion Date

December 30, 2020

Study Completion Date

December 30, 2020

Conditions
Blood Coagulation Disorder
Interventions
DRUG

0 ul of dexmedetomidine

Venous blood is taken from 11 healthy volunteers and divided into four specimen bottles, which were added with different doses (0 ul) using dexmedetomidine

DRUG

0.25 ul of dexmedetomidine

Venous blood is taken from 11 healthy volunteers and divided into four specimen bottles, which were added with different doses (0.25 ul) using dexmedetomidine

DRUG

0.5 ul of dexmedetomidine

Venous blood is taken from 11 healthy volunteers and divided into four specimen bottles, which were added with different doses (0.5 ul) using dexmedetomidine

DRUG

0.75 ul of dexmedetomidine

Venous blood is taken from 11 healthy volunteers and divided into four specimen bottles, which were added with different doses (0.75 ul) using dexmedetomidine

Trial Locations (1)

13620

Seoul National University Bundang Hospital, Seongnam-si

All Listed Sponsors
lead

Seoul National University Bundang Hospital

OTHER

NCT04269278 - Dexmedetomidine and Blood Coagulation | Biotech Hunter | Biotech Hunter